Treatment patterns of ranibizumab intravitreal injection and dexamethasone intravitreal implant for retinal vein occlusion in the USA

被引：0
|
作者：
S Nghiem-Buffet
S Baillif
S Regnier
A Skelly
N Yu
A Sodi
机构：
[1] Centre Ophtalmologique d’Imagerie et de Laser,Department of Ophthalmology
[2] Paris,Department of Ophthalmology
[3] France,Department of Ophthalmology
[4] Hôpital Avicenne,undefined
[5] Assistance Publique,undefined
[6] Hôpitaux de Paris and Paris 13 University,undefined
[7] Pasteur II University Hospital,undefined
[8] Novartis Pharma AG,undefined
[9] Novartis Ireland Limited,undefined
[10] Real-World Evidence Solutions,undefined
[11] IMS Health,undefined
[12] Careggi University Hospital,undefined
来源：
Eye | 2017年 / 31卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：551 / 559
页数：8
相关论文
共 50 条
  • [41] Repeated Treatment for Macular Edema in Vein Occlusion by Intravitreal Implant of Dexamethasone
    Matonti, Frederic
    Hoffart, Louis
    Baeteman, Christophe
    Denis, Daniele
    CASE REPORTS IN OPHTHALMOLOGY, 2012, 3 (03): : 339 - 342
  • [42] Comparison of changes in number of hyperreflective dots after intravitreal ranibizumab or dexamethasone implant in patients with branch retinal vein occlusion
    Karalezli, Aylin
    Kaderli, Sema Tamer
    Kaderli, Ahmet
    Kaya, Cansu
    Sul, Sabahattin
    TAIWAN JOURNAL OF OPHTHALMOLOGY, 2024, 14 (03) : 387 - 393
  • [43] Intravitreal Dexamethasone v/s Intravitreal Triamcinolone in Central Retinal Vein Occlusion
    Mishra, Sanjay
    Gupta, Abhishek
    Maggon, Rakesh
    OPHTHALMOLOGICA, 2014, 232 : 88 - 88
  • [44] Effect of dexamethasone intravitreal implant (Ozurdex®) on corneal endothelium in retinal vein occlusion patients Corneal endothelium after dexamethasone implant injection
    Guler, Hatice Ayhan
    Ornek, Nurgul
    Ornek, Kemal
    Gokcinar, Nesrin Buyuktortop
    Ogurel, Tevfik
    Yumusak, Mehmet Erhan
    Onaran, Zafer
    BMC OPHTHALMOLOGY, 2018, 18
  • [45] Contrast sensitivity in patients with branch retinal vein occlusion following intravitreal ranibizumab injection
    Sugiura, Yoshimi
    Okamoto, Fumiki
    Murakami, Tomoya
    Morikawa, Shohei
    Hiraoka, Takahiro
    Oshika, Tetsuro
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [46] Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study
    Alexander Rouvas
    Petros Petrou
    Ioannis Vergados
    Dimitrios Pechtasides
    Vasilios Liarakos
    Maria Mitsopoulou
    Ioannis Ladas
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2009, 247 : 1609 - 1616
  • [47] Ranibizumab and aflibercept intravitreal injection for treatment naive and refractory macular oedema in branch retinal vein occlusion
    Hogg, H. D. Jeffry
    Di Simplicio, Sandro
    Pearce, Mark S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (02) : 548 - 555
  • [48] The Outcome of Intravitreal Ranibizumab Injection for Branch Retinal Vein Occlusion Related Macular Edema
    Kilic, Adil
    Ermis, Sitki Samet
    Sari, Esin
    Yazici, Alper
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2015, 12 (03): : 199 - 202
  • [49] Intravitreal ranibizumab (Lucentis) for treatment of central retinal vein occlusion: a prospective study
    Rouvas, Alexander
    Petrou, Petros
    Vergados, Ioannis
    Pechtasides, Dimitrios
    Liarakos, Vasilios
    Mitsopoulou, Maria
    Ladas, Ioannis
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2009, 247 (12) : 1609 - 1616
  • [50] Intravitreal Ranibizumab for Macular Edema Secondary to Retinal Vein Occlusion
    Kim, Moosang
    Yu, Seung-Young
    Kim, Eung-Suk
    Bae, So Hyun
    Park, Jung Hyun
    Yu, Hyeong Gon
    Kwak, Hyung-Woo
    OPHTHALMOLOGICA, 2012, 227 (03) : 132 - 138
12345